| Authors: |
Kauffman TL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., O'Donnell EK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adams K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Beckwith JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Berman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Brantley KD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chowdhury D; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Crompton BD; Harvard Medical School, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts., Diller LR; Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Elias KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Feltmate CM; Harvard Medical School, Boston, Massachusetts.; Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts., Florez N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Garber JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Ghobrial I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hormoz S; Harvard Medical School, Boston, Massachusetts.; Department of Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kamihara J; Harvard Medical School, Boston, Massachusetts.; Boston Children's Hospital, Boston, Massachusetts.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts.; Department of Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mittendorf EA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Rodriguez NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Division of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts., Sands J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Thapa B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Weeks LD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Woo SB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, Massachusetts., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Parmigiani G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Rebbeck TR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Syngal S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts. |
